Clinical Trial Results:
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate
Cardiovascular Outcomes Following Treatment with Alogliptin in Addition to Standard of Care in Subjects with Type 2 Diabetes and Acute Coronary Syndrome
Summary
|
|
EudraCT number |
2009-011222-34 |
Trial protocol |
BE HU ES CZ SE DE FR DK IT BG LV FI LT AT SK PT GB GR |
Global completion date |
10 Apr 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
20 May 2016
|
First version publication date |
20 May 2016
|
Other versions |
|
Summary report(s) |
2009-011222-34 Results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.